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Diabetic retinopathy is one of the most common causes of blindness in the world.  From the 
data collected from nationwide studies, trends show that Diabetes mellitus is steadily 
increasing and is now evolving into a major public health problem (1).  
 
The problem we now face in India is that despite “modernisations” and implementing 
western cultures leading to an increase in sedentary life style and consumption of high fat 
foods, knowledge about the disease and early diagnosis is still lacking.  In addition, Asians 
certainly have unique clinical and biochemical abnormalities like , greater abdominal 
adiposity,  lower adiponectin levelsand increased insulin resistance. (2)   
 
Western literature have shown that 20 years after diabetes starts, majority of patients with  
diabetes Type I (insulin-dependent) and more than 60% of Diabetes type II will have some 
degree of retinopathy.(3) 
 
Just as Asians have certain phenotypical predispositions for developing Diabetes, this concept 
can be carried to other physiological characteristics such as haemodynamics, in particular our 
topic of interest, which is ocular blood flow and its regulation both in disease and health. 
 
 A great deal of research and resource has been poured into identifying the pathogenesis of 
Diabetic retinopathy. The blood supply to the outer retinal layers is from the choroidal 
vessels and the inner retinal layers are supplied by the retinal capillaries which are supplied 
by the central retinal artery. Damaging effects of chronically elevated glucose  on the retinal  
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capillary endothelial cells and pericytes  and also focal ischemia as pathogenetic factors in 
progression of disease have been well studied (4).  
 
The biochemical and cellular mechanisms that cause diabetic vasoconstriction and 
vasodilation are also starting to be ascertained.  However there are very few studies that have 
looked at choroidal blood flow as a prognostic or pathogenetic factor in the development and 
progression of Diabetic Retinopathy. 
 
The study of the choroid is being looked into as an attempt to answer some of the questions 
regarding the pathogenesis of diabetic retinopathy and how these changes are brought about 
in the retina. The pulsatile ocular blood flow (POBF) and ocular pulse amplitude (OPA) are 
indirect indicators of choroidal blood flow. Though inferences have been made from the few 
studies that have been done on choroidal blood flow, conclusions based on each study have 
been contradictory to each other. With the advent of new and more accurate measurement 
tools, more reliable data can be obtained regarding the choroidal circulation and its perfusion.  
 
Ocular blood flow can be indirectly measured non-invasively with the pneumotonometer, 
which measures the pulsatile ocular blood flow and more recently, the Dynamic Contour 
Tonometer which measures the ocular pulse amplitudes. These instruments provide the 
clinician with data that can be used to interpret the choroidal blood flow, which actually 
supplies 80% of the retina.(5) 
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Dynamic contour tonometry (DCT) is a  non-invasive technique of checking the intraocular 
pressure. It also  measures the ocular pulse amplitude of the eye being studied 
simultaneously. Ocular blood flow varies with systole and diastole. The pulsatile ocular blood 
flow (POBF) shows a peak during systole. The difference in the maximum and minimum  
values of  pulsatile wave contour during systole and diastole gives us the ocular pulse 
amplitude (OPA).  
 
In this study, we focused on documenting ocular pulse amplitudes, and indirectly the 
choroidal blood flow, in diabetic patients with various stages of Diabetic retinopathy. We 
also wanted to observe the effect of hypertension on choroidal blood flow in Diabetic 
patients. By carrying out this study, we may determine whether changes in choroidal blood 
flow play a role in either prognosticating diabetic retinopathy, or whether it proves to be a 
factor able to predict progression of diabetic retinopathy.  
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 To document the ocular pulse amplitudes in patients with various stages of Diabetic 
retinopathy 
 
 
 
 
 
 
 
 
8 
 
 
 
                                           
 
 
 
 
 
 
OBJECTIVES 
 
 
 
 
 
9 
 
 
 
 
 
 
 
1. To document any difference in Ocular Pulse Amplitudes with increasing severity of 
Diabetic retinopathy 
 
2. To document any difference in Ocular Pulse Amplitudes between Diabetics with and 
without systemic Hypertension 
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Burden of Diabetes Mellitus: 
 
According to WHO, 346 million people in the world have diabetes.(1) By 2030, the number 
is estimated to grow to 438 million ,which forms about 8% of the adult population. In 2004, 
around 3.4 million people died from complications related to diabetes mellitus(1). More than 
80% of diabetes deaths occur within low- and middle-income countries. The World Health 
Organisation (WHO) says that deaths due to Diabetes will become double by 2030. Non-
communicable diseases, which includes diabetes, account for 60% of all deaths 
worldwide.(1)    
The global prevalence of diabetes is 6.4% and WHO projects that the prevalence is from 
10.2% in the West to about 3.8% in Africa.(1) 70% of cases of diabetes occur within 
countries with low- and middle income. In India there is an estimated 50.8 million people 
with Diabetes.  
In developing countries, for every patient who is diagnosed with Diabetes, there is one patient 
who has the disease but has not been screened for it (3).  Therefore timely diagnosis and 
management are very important steps to reduce the complications due to Diabetes.  
80% of type 2 diabetes is preventable by  increasing physical activity, changing diet and 
improving the surrounding  environment. Yet, the incidence of diabetes is likely to rise 
globally(1).  
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Economic burden of disease: 
The financial burden caused by people with diabetes and their families depends on the 
economic status in which there are in.  Unfortunately, the insurance policies are not very 
great for people in the poorest of countries and therefore the families have to take care of the 
whole financial burden of disease. 
 
Diabetic retinopathy in India: 
 
The prevalence of Diabetic Retinopathy in the Chennai Urban Rural Epidemiology (CURES) 
Eye Study in Southern India was 17.6 per cent where 1715 diabetic subjects were studied. 
This was a population based study done in 10 zones in Chennai, which included a 
representative sample of the population of 26,000 individuals. Diabetes was diagnosed based 
on the past medical history and also medications for diabetes. duration of diabetes, degree of 
glycaemic control and hyperlipidaemia were found to be the main risk factors for onset and 
progression of disease. (6) 
 
 Among the 1715 known Diabetics, the overall prevalence of Diabetic retinopathy was found 
to be 20.8 per cent, while among the newly diagnosed diabetic subjects 5.1 per cent had 
retinopathy.  The Prevalence of Diabetic macular edema in the total diabetic population was 5 
% and in the known diabetic subjects it was 6.3%  and 1.1 % among the newly diagnosed 
diabetic subjects. (6) 
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In another study,  R P Agrawal et al (7) found that  out of  a total of 4067 patients with 
Diabetes who presented to an outpatient diabec clinic, 1176 patients (28.9%) had findings of 
some Retinopathy .  Among these, 79.8% of patients had non proliferative diabetic 
retinopathy (NPDR), 5.8% of  patients had maculopathy and 14.6% of  patients had 
proliferative retinopathy.(8) 
 
R Raman et al. (9) did a multicentric random sampling of the population in Chennai for  
screening for diabetic retinopathy. The sample size was 5900. They found the prevalence of 
Diabetes to be 28.2% and the prevalence of diabetic retinopathy to be 3.5%. (9) 
 
Ramachandran A et al (9) conducted a study among 3010 subjects (M:F 1892:1118, Mean 
age 52 +/- 9.7 years) attending an outpatient diabetic clinic. The study sample resembled the 
population sample. Retinopathy was diagnosed in 23.7% (nonproliferative retinopathy in 
20.0% and proliferative in 3.7%). (10) 
 
 
Pathophysiology in Diabetic retinopathy: 
 
Diabetic retinopathy is essentially a microangiopathy in which there is leakage  in the blood –
retinal barrier, resulting from  damage to the walls of the arterioles supplying the retina. 
Hyperglycaemia can lead to a wide variety of microvascular and macrovascular 
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abnormalities, including abnormal autoregulation. (9) As described by Ciulla et al. , chronic 
hyperglycemia leads to a change in retinal vasoregulations. This increases bulk retinal blood 
flow with progressive retinopathy, perifoveal capillary dropout. In turn, there are retrobulbar 
hemodynamic abnormalities, including choroidal, central retinal arterial flow changes and 
ophthalmic arterial flow changes.(9)  Having said that, the factors that link raised glucose 
levels to , vascular cell dysfunction, capillary dropout, and tissue hypoxia have not been 
elucidated.  
 
 
Ocular blood flow response to hyperglycemia: 
 
With regard to the macrovascular pathophysiology, Bursell et al (9) found that chronic raised 
sugars are associated with a decrease in blood flow in the retina , but the retina is still capable 
of autoregulating this by increasing retinal blood flow according to the acute elevations in 
blood glucose. Their study with video fluorescein angiography (n=60) suggest that as 
compared to normal ocular blood flow, there is a reduction in ocular blood flow in diabetic 
patients without  any retinopathy.  
 
When patients had been exposed to acute increase in glucose levels, there was an increase in 
retinal blood flow within one hour. The retinal blood flow with progressively increasing 
sugar levels were as follows: with the glucose clamp at 100 mg/dl , the retinal blood flow was 
16.3 ± 3.8 AU (arbitrary units); with the Glucose clamp at 200 mg/dl:  21.5 ± 4.7AU, with 
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the  glucose clamp at 300 mg/dl : 25.9 ± 8.8 AU and in the Random diabetic group, it was 
19.4 ± 4.6 AU. In the non diabetic group: 28.7 ± 6.4 AU. They suggest that there is an 
association between elevated blood sugar levels and reduced retinal blood flow. In spite of 
this, the retina is able to autoregulate in response to increased metabolic needs. 
 
Retinal blood flow studies: 
 
 Different studies have found different results of increased, decreased or no changes in the 
ocular blood flow in various stages of diabetic retinopathy.  
 
Kohner et al (11) studied retinal  blood flow 36 diabetic patients and 9 normals using video 
fluorescein angiography. In their studythey measured  mean transit time of flourescein in the  
retina and estimated vessel volume by measuring vessel diameter. They found  that there was 
increased volume flow in diabetic patients with mild or no retinopathy as compared to 
normals. They also found that patients with moderate retinopathy had a slight increase . 
Severe retinopathy patients had blood flow similar to non diabetics. 
 
Clermont et al (12) showed that the retinal blood flow increased as the stage of retinopathy 
increased. In this study, 48 diabetic and 22 non-diabetic patients had their diabetic 
retinopathy levels estimated from fundus photographs according to  the Early Treatment 
Diabetic Retinopathy Study (ETDRS). Fluorescein angiograms were recorded from the left 
eye by video fluorescein angiography. Retinal blood flow decreased 33% in patients with 
mild retinopathy compared with control patients (P = .001) and increased sequentially in 
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more advanced stages of retinopathy, with a strong correlation between retinal blood flow 
and retinopathy level (r2 = 0.434, P = .001)   
 
The increase in perfusion of retina during pre-proliferative retinopathy probably arises from 
thickening of basement membrane capillaries leading to occlusive angiopathy and tissue 
hypoxia . This in turn increases demands further (13)(14).  They also found  that the retinal 
capacity to autoregulate is blunted in subjects with diabetes (15,16)  
 
Grunwald et al (15) showed in a study using  LASER Doppler Velocimetry (n=77) that 
breathing 100% oxygen reduces retinal blood flow. In diabetics without any retinopathy total 
flow decreased only 53% , 38% in patients with background retinopathy, by 61% in normal 
eyes, and only 24% in eyes with proliferative retinopathy. Loss of  normal  response to 
elevated PO2 suggests that the ability to decrease bulk retinal flow when there is increased 
oxygen delivery, is gradually reduced as the disease progresses.(16) 
 
Rassam et al (17) studied the effect of hypertension on haemodynamics of the choroid and 
retina and studied the autoregulatory ability of the retinal vessels in the presence of normal 
blood sugars and also hypoglycemia. Retinal blood flow was measured in 10 normal control 
subjects, 10  subjects with Diabetes with blood glucose < 10 mmol/L and 10 subjects with 
diabetes with blood glucose > 15 mmol/l' before and after increasing the  blood pressure .  
Laser Doppler velocimetry was utilised. Results showed that when the mean arterial pressuer 
increased by 40 %, there was an  increase in retinal blood flow of 32.9 + 7-1 % in controls 
(non diabetics). In diabetics with  low blood glucose level, the increase in retinal blood flow 
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was significant when there was  30% increase in Mean Arterial Pressure (23.6 + 87 %, P = 0-
032) and at 40 % increase (49-9 + 12-03 %, P = 0-004). Diabetics with hyperglycemia failed 
to show any sign of autoregulation at any of the increased levels of Mean Arterial Pressure 
(with 15 % increase, 27 0 + 11 1 %;  with 30 % increase, 66.9 + 19.8 %; and with 40 % 
increase, 101 9 + 21 4 %; P < 0.022). The coefficients of autoregulation showed that in 
controls, retinal vascular autoregulation broke down with increases in Mean Arterial Pressure 
between 30 and 40 %. In diabetic subjects, it broke down between 15 and 30 % in patients 
with normal sugars and at less than 15 % when sugars were high. They hypothesised that 
there was a defect in autoregulation in response to elevated blood pressure in diabetics, even 
more so with hyperglycemia. 
 
Schemetter et al. (18) showed that the sensitivity of the beta-adrenergic receptors of ocular 
vessels of diabetics is less than that of control subjects. LASER interoferometry was used. 
(18) Eyes (n = 214) were classified according to modified Airlee classification into 4 groups. 
They found that fundus pulsation amplitudes were significantly less in patients with 
proliferativce diabetic retinopathy (P < 0.027).  
 
 
Evans et al. (19) studied retrobulbar blood flow velocities using color Doppler in 22 subjects, 
11 of whom were diabetics with no or minimal diabetic retinopathy, and the other 11 were 
controls. They did so in normal air and also in hyperoxic conditions. They found that 
hyperoxia induced a significant change in the central retinal artery’s end diastolic velocity in 
the control group. However in the diabetic group, this change was not appreciated. Also, the 
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resistance index in normals increased under conditions of hyperoxia.. They concluded that 
hyperoxia does reduce central retinal artery end diastolic velocity and increase resistance 
index in normal people and this change may not be seen in diabetics.(19) 
 
Patel et al.   (20) compared 24 controls with no diabetes with 76 patients who had diabetes. 
Among the diabetics, no  retinopathy patients were 12,  background diabetic retinopathy :27, 
pre-proliferative diabetic retinopathy :13, and proliferative diabetic retinopathy:12, and 12 
were post pan retinal photocoagulation.  When comparing non-diabetic and diabetic patients 
with no diabetic retinopathy,  retinal blood flow was increased substantially in all stages of 
diabetic retinopathy untreated. They concluded that retinal blood flow is substantially 
elevated in subjects with diabetic retinopathy in comparison with normal subjects and 
diabetics without retinopathy.  
 
Mendivil et al. (21) compared 25 eyes in 25 patients with proliferative diabetic retinopathy 
before LASER and 6 months and  12 months after pan retinal photocoagulation with a control 
group of 30 . The ophthalmic artery and  central retinal vessels of all patients were 
eestimated. The systolic, diastolic, and mean arterial velocities were found. In both the 
ophthalmic artery and the central retinal artery, blood velocities were lower in the diabetics. 
Also, pan retinal photocoagulation significantly reduced blood flow velocities. As compared 
to controls, patients with proliferative diabetic retinopathy had lower ocular perfusion 
pressures. Those who received pan retinal photocoagulation continued to have lower blood 
flow velocities during the one year follow up in the study. 
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Feke et al. (22) used laser Doppler technique and monochromatic fundus photography to 
measure retinal circulatory parameters in 39 patients with type 1 diabetes with duration of 
diabetes between 7 and 20 years and 13 age-matched controls without diabetes. Blood 
pressure, intraocular pressure, and heart rate were measured in all subjects. Glycosylated 
hemoglobin was measured in the patients. Retinopathy was assessed using standardized color 
fundus photography and fluorescein angiography. They concluded that the retinal circulation 
of patients with type 1 diabetes with no retinopathy or background retinopathy is 
characterized by dilated major arteries with reduced blood speeds. 
 
 
Effects of diabetes on retrobulbar blood flow: 
 
As the retina is supplied by the central retinal artery, we would expect some changes in the 
central retinal artery hemodynamics in patients with diabetes. Guven et al.  (23) showed in 
seventy-three eyes in 37 patients with diabetes that the CRA maximum blood flow velocity 
levels were significantly higher in the pre-retinopathy group (9.8 +/- 2.1 cm/second) than in 
the non-PDR group (8.1 +/- 2.2 cm/second). Color Doppler imaging was used to quantitate 
peak systolic blood flow velocities of the central retinal artery (CRA). (n=37) In addition, the 
CRV maximum blood flow velocity levels were significantly higher in the pre-retinopathy 
group (5.7 +/- 0.9 cm/second) than in both the PDR group (4.8 +/- 1.5 cm/second) and the 
PRP group (4.9 +/- 1.7 cm/second) 
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Goebel et al. (24), using color Doppler imaging, studied 146 diabetic eyes, (61 proliferative, 
59 non proliferative and 26 preproliferative retinopathy) and compared it with 126 eyes of 70 
controls. He showed that proliferative retinopathy strongly correlated with decreased flow 
velocities in the retrobulbar vessels, mainly the central retinal artery. These findings only tell 
us that there is change in the retrobulbar blood flow. Whether these changes in the retrobulbar 
circulation are partly a cause of retinopathy or an effect of dysfunctional autoregulation is not 
clear.  
 
 
Choroidal changes in Diabetes- Diabetic choroidopathy: 
 
In patients with Diabetes, the choroid undergoes changes which are not clinically picked up 
easily. These include an increase in the tortuosity of the vessels, localised areas of vascular 
dilatation and narrowing, presence of vascular loops and the formation of microaneurysms. 
Histological analysis of the human choroid shows areas of capillary drop outs and capillaries 
that are beaded. Fluorescein angiography showed delayed choroidal perfusion, and 
electroretinograms with abnormal oscillatory potentials in the same diabetic patients. (25) 
 
Another study found that some of the risk factors for developing choroidopathy were the 
severity if diabetic retinopathy, degree of diabetic control and stringency of diabetic 
treatment regimen. (26) 
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Studies on choroidal blood flow : 
 
Upto 80% of the aerobic metabolism of the retina is supplied by the choroid.(5)( Retinal 
blood flow represents only about 4 percent of total ocular blood flow. The choroidal blood 
flow on the other hand ranges from 500 to 2000 ml/min/100g tissue. The mechanisms 
controlling ocular blood flow are of different types: systemic, local, neural, endocrine, 
paracrine.  
 
Since the retinal and choroidal arterioles do not possess sphincters, blood flow in these 
tissues is only a function of the muscular tonus of the arterioles and possible the state of 
contraction of the pericytes. Vessels tonus is modulated by the interacted of multiple control 
mechanisms: myogenic, metabolic , neurogenic, and humoral, which are mediated by the 
release of vasoactive molecules by the vascular endothelium or by the glial cells surrounding 
the vessels.  
 
We know that there is retinal autonomic dysregulation in diabetic retinopathy. We also know 
that the choroid is regulated by the autonomic nervous system. What has not been studied to a 
great extent though is whether there is any autonomic dysregulation of the choroidal blood 
flow in Diabetic patients. (9)  
 
In normal individuals, the choroid has a linear relationship with the pulse pressures. This 
indicates a lack of autoregulation capacity of the choroid in response to increased pulse  
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pressures. In the choroid, an increase in arterial pressures causes the sympathetic nervous 
system to increase the peripheral resistance.(5) 
 
Due to the recent advance in tools to measure choroidal blood flow, a great deal has been 
learnt about how the blood flow within the eye occurs and how it changes with various 
stresses in the body. POBF and  OPA are indirect indicators of choroidal blood flow can be 
measured by techniques like laser interferometry, colour Doppler imaging,  laser Doppler 
flowmetry and  pneumotonometry.  
 
Polska et al (23)  found these various techniques reproducible in healthy individuals.  Laser 
interferometry assesses fundus pulsation amplitude. Colour Doppler imaging assesses blood 
velocities in the ophthalmic and posterior ciliary arteries.  Laser Doppler flowmetry assesses 
choroidal blood flow, volume, and velocity using  fundus camera.  
 
Pulsatile ocular blood flow (POBF) can be measured using the pneumotonometer  (ocular 
blood flow) system. (28) During the measurement using the pneumatic applanation 
tonometer, the instrument assesses changes in the intraocular pressures caused by the cyclic 
filling and draining of the choroidal vessels. The maximum difference between the systolic 
and diastolic blood pressures during the cardiac cycle is called the pulse amplitude (PA).  
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Theoretically,  POBF is measured from variation in intraocular pressures over time. This   
works on the basis that venous blood outflow from the eye is not pulsatile. Also,   ocular 
rigidity is taken to be equal in all patients. The calculation of POBF is automatically taken 
from five pulsations which are most close in beat-to-beat variation. (28) 
 
 
Studies on POBF: 
 
Savage et al. (29) conducted a study using the Langham pneumotonometry on patients with 
Non Proliferative Diabetic retinopathy. Out of the 77 diabetics, 13 had mild or no 
retinopathy, 36 had moderate to severe retinopathy and 28 had proliferative retinopathy. All 
patients with proliferative retinopathy had pan retinal photocoagulation (PRP). Patients with 
moderate to severe non-proliferative diabetic retinopathy (NPDR) had POBF which were 
18% higher than the control group (mean ocular blood flow : 943 µL/min). IN post PRP 
patients, ocular blood flow was 22% below the control (mean ocular blood flow: 619 
µL/min), and 34% less than the severe retinopathy group.  
 
 Diabetic patients with no retinopathy and those with mild NPDR had Ocular blood Flow 
which were indistinguishable from the control group (785 ul/min vs. 797 µL/min). He 
concluded that POBF is unaffected during the early stages in diabetic retinopathy, but 
gradually increases as the stages of retinopathy increases. He also found that the pulse ocular 
blood flow decreases after LASER pan retinal photocoagulation .(29)  
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McKinnon et al, (30) using a pneumotonometer - slit lamp arrangement, studied mean 
pulsatile ocular blood flow in patients with various stages of Diabetic retinopathy. Among the 
82 patients studied, there were 22 controls, 20 diabetics with no retinopathy, 20 with 
background retinopathy, and 20 with non proliferative diabetic retinopathy. Compared to the 
control group, it was found that the pulsatile ocular blood flow was increased in all grades of 
retinopathy. The most significant of this was comparing controls versus those with 
background retinopathy (p<0.05). They also found that as the intensity of retinopathy 
increased, the POBF also increased. The mean pulsatile ocular blood flows were as follows: 
controls: 644ul/min; background retinopathy: 1015 ul.mim; no retinopathy: 818 ul.min; and 
preproliferative retinopathy 1097ul/min (30)  
 
Dimitrova et al. (31) studied choroidal blood flow changes in diabetic patients with and 
without diabetic retinopathy . He used color Doppler imaging to study the end diastolic 
velocity and the resistance index. He found that in patients with Diabetic retinopathy, the end 
diastolic velocity significantly decreased (2.55+-1.08 cm/s vs 3.23+-1.08 cm/s) and the 
resistance index significantly increased (0.70+-0.08 vs 0.62+- 0.06) . Therefore, it was 
reemphasised that choroidal circulation was proven to be affected in patients with diabetic 
retinopathy. 
 
Langham et al. (32)   proposed that  the cause for the decreased choroidal circulation in 
patients with Diabetic retinopathy was increased peripheral resistance and decreased ocular 
perfusion pressure.  
25 
 
 
 
Nagoka et al (33), using LASER Doppler flowmetry, determined the choroidal blood flow in 
the fovea of 70 patients with non insulin dependent diabetes Mellitus. There were also 36 
controls. Out of the 70 patients, 33 had no Diabetes (NDR), 20 had non-proliferative 
retinopathy and no macular edema (NPDR-MO) and 17 had non proliferative retinopathy 
with edema at the macula (NPDR+MO). Foveal thickness was measured using Optical 
coherence tomography. They found that of all the groups, the group with NPDR with macular 
edema had significantly decreased choroidal blood flow compared to the controls. (13.5 vs 
5.6 AU) further reiterating that choroidal blood flow is altered in diabetic retinopathy and 
more so in patients with macular edema. 
 
LASER interferometry studies on fundus pulsation magnitude have been done and these fail 
to show any significant difference in choroidal blood flow in diabetics compared to normals. 
(18,34)   Guven et al. showed that blood flow velocities in the arteries feeding the choroid 
are also changed by Diabetes. (23)  
  
Studies done on ocular pulse amplitudes: 
 
Schmidt et al(25) studied  OPA, using the Langham ocular blood flow (OBF) 
pneumotonometer system. Ocular pulse ampllitudes were measured in diabetic patients with 
no retinopathy (n=22) , non proliferative (n=24) and proliferative retinopathy (n=18). He 
found no significant difference in OPA between the sub groups and therefore concluded that 
the OPA does not change with the progression of retinopathy. 
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Geyer et al. (35)studied pulse amplitude (PA) and pulsatile ocular blood flow (POBF) using 
a pneumotonometer. Participants were grouped into 4 categories: normal controls (n=26), 
diabetes with no retinopathy (n=18), moderate non proliferative retinopathy (n=20) and 
severe non proliferative and proliferative retinopathy (n=12).  
 
Results showed that there was an initial dip in the pulsatile ocular blood flow during early 
stages of Diabetic retinopathy and then in more severe stages, there was an increase in the 
pulse ocular blood flow.(35) Geyer observed that the ocular pulse amplitude was lower in 
diabetics with no retinopathy as compared to normal subjects and participants with 
documented diabetic retinopathy.  They also found that the ocular blood flow increased as the 
progression of diabetic retinopathy increased. They hypothesized that the low POBF in the 
non-diabetic-retinopathy patients correlated with the histological features of chorio-capillaris 
degeneration and basal lamina deposits. In proliferative retinopathy, they hypothesise that the 
choroid also has an analogous condition- “Diabetic choroidopathy”. 
   
Geyer et al. showed the following in their study on OPA with the Langham OBF system. The 
pulse amplitudes were 2.8 , 1.8, 2.7 and 2.9 mm Hg in each of the groups controls, diabetics 
with no retinopathy, non proliferative diabetic retinopathy and proliferative retinopathy. 
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 Control NDR NPDR PDR 
Number 26 18 20 12 
Pulse 
amplitudes 
2.8 (1.0) 1.8 
(0.7) 
2.7 (0.8) 2.9 (0.9) 
Significance 
compared to 
ndr 
P<0.001  P=0.55 P=0.83 
Pulse ocular 
blood fow 
(ul/sec) 
13.7 (4.5) 8.8 
(3.4) 
11.7 (2.1) 18.3 (3.8) 
Significance 
compared to 
control 
 P< 
0.001 
P=0.054 P=0.003 
 
 
 
The above mentioned studies of on OPA, the OPA has been measured using the 
pneumotonometer. Dynamic contour tonometer (DCT) , a relatively newer instrument used to 
measure IOP can be also be used to measure OPA (more details elaborated later). To date 
there are no studies of OPA in diabetics as measured by DCT. 
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Factors affecting ocular blood flow 
 
Effect of Pan Retinal Photocoagulation on ocular blood flow: 
 
Pan retinal photocoagulation alters retinal and retrobulbar blood flow and these changes last 
for at least 2 years. There is also evidence that pan retinal photocoagulation has an affect on 
the choroidal circulation as there is destruction of the choriocapillaris. This theoretically can 
reduce the amplitude of the ocular pulse pressure.(20)(21)(29)(36)(37) 
   
 
Effect of age on ocular blood flow: 
 
The blood flow into the eye decreases with age.(38) Also, the pulse ocular blood flow 
decreases as the intraocular pressures increase. (38) Having said that, in primary open angle 
glaucoma, the pulse ocular blood flow was shown to decrease. (39) 
 
 
Effect of gender on pulsatile ocular blood flow: 
 
Gekkieva et al. (40) observed in their study comparing the ocular pulse amplitudes and 
ocular blood flow in men and women. They found significantly increased POBF (722.6 ± 
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152.8 in females versus 647.8 ± 1164.9 in males  p=0.056) and OPA(2.3 ± 0.7 in females 
versus 2.0±  0.6 mm Hg in males) in females as compared to males.  
 
Ocular Blood flow and Hypertension: 
 
Blood pressures do not seem to affect the ocular pulse amplitude. (41) (42) These studies 
were done among normal subjects. They hypothesized that this lack of significant change in 
OPAs were due to the regulatory mechanisms of the baroreceptors in the carotid system 
before blood reached the choroidal circulation.(41) Also, in another study,  they found that 
the presence of Hypertension altered the choroidal circulation, influencing any results that 
may be interpreted based on ocular pulse amplitudes in Diabetics with HYpertension. They 
found that in the presence of Hypertension, the choroidal blood flow increases in patients 
with Diabetes as compared to patients without Hypertension.(43) 
 
Ocular blood flow and pulse amplitude studies in India: 
The Ocular pulse amplitude has not been studied extensively within the Indian population. In 
New Delhi, Agarwal et al. found that the pulse ocular blood flow in normal Indian 
individuals was higher than that of the Caucasian population(7) 95 normal subjects were 
selected. 41 males and 54 females. The pneumotonometer OBF system was used for all the 
measurements. The mean pulse amplitude obtained among the normal subjects was 3.4±1.46 
mm Hg.  
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There is no published data on the normal range of ocular pulse amplitudes among the Indian 
subcontinent, nor any on the ocular pulse amplitudes of diabetic patients using the Dynamic 
Contour Tonometer. With this study we aim to document the above in the context of the 
Indian subcontinent. 
 
Ocular pulse amplitudes in Glaucoma: 
The variations of OPA in glaucoma has been well studied. Most studies show that there is a 
reduction in the ocular pulse amplitudes in patients with primary open angle glaucoma. (44) 
In normal eyes in which the intraocular pressures were mechanically raised, with the raise in 
Intraocular pressures, the ocular pulse amplitudes increase. There is a direct relationship 
between the ocular pulse amplitudes and the ocular rigidity. (45) 
 
Relationship of ocular pulse amplitudes and axial length: 
Similarly, the variations of OPA in normal subjects have shown that OPA varies with the 
axial length of the eye. (46)(47) Kaufmann showed a negative correlation between OPA and 
axial length (0.27 mm Hg/1 mm of length; P<.001) (48) 
 
Ocular pulse amplitudes in Retinitis Pigmentosa patients: 
OPA measures by the ocular blood flow system showed a significant decrease in the OPA 
with increasing severity of Retinitis Pigmentosa. (49) The study was done to see if there was 
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a decrease in choroidal perfusion in patients with increasing severity of Retinitis Pigmentosa.  
Therefore, in the conducted study, patients with Retinitis Pigmentosa were not selected to be 
enrolled in the study. 
 
 
Ocular pulse amplitude in patients with age related macular degeneration: 
In early ARMD, there is an increase in the choroidal blood flow, and in advancing severity of 
age related macular degeneration, there is a reduction in the choroidal blood flow and 
volume. (34)  
 
Mori et al. (50) in their work showed that the POBF and PA are reduced in patients with 
exudative type of age related macular degeneration (AMD) in comparison to normal controls 
and those with dry age related macular degeneration. They recruited  10 patients with dry 
AMD, 11 patients with exudative AMD, and 69 normals matched for age.  The significance 
of difference in pulse amplitudes between the exudative AMD group (PA=1.2 mm Hg) and 
non-exudative AMD (PA=2.2mm Hg) was p= 0.04. Similarly, the significance of difference 
between the exudative AMD group and the controls (PA= 2.0mm Hg) was p=0.01. They 
concluded that the decrease in choroidal blood flow may have a pathophysiological role in 
developing exudative age related macular degeneration with neovascularisation. 
 
Ciulla et al. (51) analysed  flow velocities using color doppler in several retrobulbar vessels 
in 2 groups of patients: those with non exudative AMD (n=25) and those with no AMD 
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(n=25).  They found a trend toward reduced bulk ocular blood flow in patients with non 
exudative AMD as compared to normals.  Therefore they concluded that choroidal perfusion 
is altered in even non-exudative AMD. 
 
 
Dynamic Contour Tonometry: 
 
Dynamic contour tonometry (DCT) is a new non-invasive technique of checking the 
intraocular pressure. It also simultaneously measures the ocular pulse amplitude of the eye 
being studied. Ocular blood flow varies with systole and diastole. This pulsatile ocular blood 
flow (POBF) shows a peak during systole. The difference in the minimum and maximum 
values of the pulsatile wave contour during systole and diastole gives us the ocular pulse 
amplitude (OPA). The OPA is an indirect indicator of the choroidal perfusion.(42)(52) 
 
The Pascal DCT is one such device which can be installed into the optical axis of a slit lamp. 
The tonometer head piece consists of a cylindrical head with a surface contour which comes  
 
 
into contact with the corneal surface and becomes equal to the contour of the cornea when the 
pressures on both sides are equalized. The sensitive part of the head is only 0.25mm
2.  
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 The Pascal software measures the intraocular pressure and its variation with every heart 
beat- the ocular pulse amplitude. The values are shown on an LCD display. The signals are 
stored in a computer via a wireless unit and the results are thus displayed and stored for 
further data analysis.  
 
The intraocular pressures measured by the PASCAL dynamic contour tonometer are more 
accurate than the Goldmann applanation tonometer. The intra observer and inter observer 
variability was about 0.65 and 0.44 for the DCT and 1.11 and 2.38 mm Hg for the Goldmann 
applanation tonometer. This accuracy of the DCT can be accounted by the fact that the 
readings are electronic. (53) They also found that with DCT, the intraocular pressures 
reduced from the first to sixth readings.  This is due to the repeated pressure over the eye as 
the readings are taken. Similarly, we suspect that there may be changes in the ocular pulse 
amplitudes of patients when repeated readings are taken, therefore an average of 3 readings 
are taken, with quality index 1 or 2. (54) 
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Studies using dynamic contour tonometer: 
 
Kaufmann et al (48) found a median  value of ocular pulse amplitudes of  3.0mmHg among 
the 223 eyes studied, ranging  from 0.9 – 7.2 mm Hg. He observed that the following had no 
bearing on the ocular pulse amplitudes: central corneal thickness, corneal curvature, anterior 
chamber depth, age and sex. There was an association between intraocular pressures and 
ocular pulse amplitudes (0.12mm Hg for every 1 mm Hg in IOP) They also found that the 
OPA reduced with increased axial lengths (0..27mm hg for every 1 mm ). 
     
Hoffmann et al described a mean ocular pulse amplitude value of 3.08± 0.92 mmHg. (55) in 
his study in which Dynamic contour tonometry was used for measurement in a group of 19 
eyes .  
 
Pourjavan et al (42), found a mean OPA of 2.2 +-0.7 mm Hg with a diurnal variation of 0.4 
mm Hg in a prospective study with 52 eyes of 28 normal subjects. They found that there was 
no significant difference in the mean OPA levels at any time in the diurnal curve. Neither 
blood pressure nor age had a significant bearing on the readings of OPA.  
  
To date there are no studies of OPA in diabetics as measured by DCT-. We conducted this 
study to look at the OPA in varying grades of diabetic retinopathy and if presence of 
hypertension could affect the OPA in these patients. Also, we conducted the study to have a 
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baseline in the ocular pulse amplitudes in this region in south India, the only other study of 
ocular pulse amplitudes being done in the north of India. 
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Materials and Methods 
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Study Design: observational study 
 
Study population:  
1) Patients diagnosed to have diabetes  in the Medicine/ endocrinology department of CMCH 
and referred to the  Department of Ophthalmology, CMCH  for evaluation  for diabetic 
retinopathy. 
2) Known diabetics and are undertaking treatment in the Department of Ophthalmology, 
CMC Vellore.   
3) Patients who are not known diabetes who presented either to our outpatient facility or 
camp facility were screened for diabetes and were included in the diabetic/ no diabetic group 
as per the blood results (the inclusion criteria as given below).  
 
Institutional Review Board clearance:  The study was cleared by the institutional ethics 
and research committee of the Christian Medical College, Vellore. Ref. No: …… 
(appendix1) 
 
Location:  Department of Ophthalmology, CMC Vellore. 
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Inclusion criteria:   
 
Patients were enrolled into the study if they belong to the following criteria: 
1. For group 1 (No DM), patients had no history of Diabetes or having taken 
medications for Diabetes in the past. TO confirm absence of Diabetes Mellitus, based on the 
American Diabetic Association guidelines for Diabetes diagnosis 2011 (49) . HbA1C levels 
were done for all patients that were enrolled for the study (HbA1C of more than equal to 6.5 
mg/dl were diagnosed as diabetics). Therefore, All patients with A1C levels of < 6.5 mg /dl 
were selected under this group  
 
2. For group 2 (DM with no DR), they required one of the following criteria before 
being enrolled into the study: 
a. Chronic history of Diabetes, on oral hypoglycemic medications 
b. Recently diagnosed Diabetics ( based on ADA guidelines) 
 
3. For group3 (DM with DR), they required presence of diabetic retinopathy to be 
enrolled in to the study. 
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Hypertension was diagnosed based on the Joint National Committee - 7  report as patients 
who had blood pressure readings of more than equal to 140/90 mm Hg in two or more 
readings*.  
 
 
Exclusion criteria:  
 
1. Active retinal pathology other than diabetic or hypertensive retinopathy 
2. Any intraocular surgery in the past 1 year in the eye chosen to be examined 
3. No clear view to the fundus 
4. History of cerebro-vascular event 
5. History of connective tissue disorders and hematological disorders 
6. Patients with proven glaucoma 
7. Ocular hypertensives (those with corrected intraocular pressures more than 24mm Hg) 
8. Suspicious discs (suggestive of glaucoma) 
9. History of any chronic topical ocular medications being used. 
10. Corneal disease which prevents DCT measurement.  
 
In addition , presence of HbA1C>6.5 mg/dl was an exclusion criteria for group 1 (No DM) 
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Methodology 
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Participants who consented to take part in the study were divided into 3 sub-groups based on 
their clinical presentation: No diabetes (No DM group) , Diabetics with no retinopathy (DM 
with no DR group), Diabetics with retinopathy (DM with DR group). For each patient, the 
right eye was chosen by default unless the right eye had a contraindication for the same.  
 
Patients without Diabetes (No DM)  were mostly in-patients who were planned on being 
operated for cataract surgery the following day. For all patients without Diabetes, blood was 
sent for serum HbA1C levels on the same day, irrespective of whether an AC/PC was done in 
the recent past. Blood samples were taken in the ward for the admitted patients by trained 
nursing staff or by the primary investigator. For the few patients who were selected with 
consent from the outpatient department, blood was withdrawn at the laboratory in the Eye 
Hospital, CMC Vellore. All the blood samples were tested in the Biochemistry Laboratory 
under the Department of Biochemistry, CMC Hospital Vellore.  
 
Funding for the blood test was by the research fund. A/c no 22X873 (appendix) Patients who 
were found to have HbA1C levels above 6.5 were discontinued from the study.  
 
Patients with Diabetes, with or without retinopathy were approached through the out-patient 
department in the Eye Hospital, CMC Vellore.  
 
Diabetic patients (with or without Diabetic retinopathy) were identified by doctors in the 
outpatient department and referred to the principal investigator for further evaluation after 
orienting each patient briefly on what the study involved.  
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The patients were then explained in detail about what the study involved, the minimal risks 
involved, and the possible benefits from the study. If they were willing for the same, they 
were recruited.  
 
Having given consent for participation in the study, the participants again underwent a dilated 
fundus examination by the principle investigator using a 90 D condensing lens assisted by a 
Haag Streit slit lamp in order to confirm absence of exclusion criteria. This also enabled 
uniformity in the protocol in checking ocular pulse amplitudes after dilatation, as there are 
possible effects of mydriatics on the autonomic regulation of blood flow within the eye.  
 
Patients with Diabetic retinopathy were classified based on the modified Airlee staging 
standard photographs into mild , moderate, severe and very severe non proliferative diabetic 
retinopathy and proliferative diabetic retinopathy.  
 
Based on the clinical findings, patients underwent OCT and FFA where indicated based on 
the protocol followed in the department of Ophthalmology, CMC Vellore.  
 
Once all the exclusion criteria were eliminated, the patients underwent blood pressure 
measurements by trained staff in the department of Ophthalmology. Blood pressures were 
checked in the sitting position, after 10 minutes of waiting, in the right arm, except in those 
who had a contraindication for the same. The BP cuff and the sphygmomanometer were 
placed approximately at the level of the heart. 
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 If the blood pressures were recorded to be more than equal to 140/90 mm Hg, they were 
rechecked after an hour. If the blood pressures were still more than 140/90 mm Hg , the 
patients were either referred to department of Medicine, CMC Vellore (if affordable) or the 
Low Cost Effective Care Unit CMC Vellore, for further management. 
 
Once all the exclusion criteria were eliminated, patients underwent Ocular Pulse Amplitude  
measurements using the PASCAL Dynamic Contour Tonometer after entering preliminary 
information about the patient on the proforma sheet.(appendix2) 
 
Once the PASCAL DCT unit was attached to the Haag Streit slit lamp, a drop of topical 
paracaine 1% was instilled. Having confirmed that the patient was comfortably seated and not 
straining to place his or her chin on the chin rest, the head was kept leaning on the head rest. 
The sensor tip of the DCT unit was then brought close to the cornea, with the patient fixing 
on a target straight ahead with the left eye. A darkened area in the centre of the sensor tip 
cover (approximately half of the diameter of the visualised sensor tip area) represented the 
area in contact with the eye. Visualisation was with the left eye piece, using the right eye of 
the observer.   
 
3 values of either quality score 1 or 2 were taken and entered in the proforma (appendix 2). 
Intraocular pressures (which were automatically displayed on the screen along with the 
Ocular Pulse Amplitude values) were also noted down to confirm absence of ocular 
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hypertension, which has been hypothesised to affect the pulse ocular blood flow and therefore 
the ocular pulse amplitude. 
 
The measured data was then transferred to a devoted computer via a blue tooth device.  
All the ocular pulse amplitude readings were taken by the principal investigator. 
 
Contact details were not obtained for all patients as they did not require follow up visits. As 
all the patients examined had a CMC hospital number, the Patients who were found to be 
Diabetic based on HbA1C levels were advised to get an OPD check up in the Low Care 
Effective Care Unit/ department of general medicine or Endocrinology, Christian Medical 
College Hospital Vellore. 
 
Each proforma was stored in a file for future reference with date. Age and sex were 
documented along with the date of testing. History of Hypertension and whether on 
medications was also noted. The details of medications which the patients was on was also  
noted as some antihypertensives had a intraocular pressure lowering effect and therefore may 
have had an effect on the ocular pulse amplitude.  
 
 
Sample size calculation: 
 
Based on results of Orna- Geyer et al,(35) on ocular blood flow and ocular pulse amplitude 
using pneumotonometry, there was a significant difference in ocular pulse amplitudes 
45 
 
 
between diabetics with no retinopathy and normals. Non proliferative and proliferative 
retinopathy did not show to have any significant difference from the normal mean. They 
found a mean difference of 1.0 between the normal (2.8 mm Hg; SD=1.0) and diabetics with 
no retinopathy (NDR= 1.8 mm Hg; SD 0.7).  
 
Taking this data, with alpha error of 5% and power of 80%, we calculated the sample size 
required in each subgroup and found it to be 12. We then decided to club all diabetic patients 
that showed some features of Diabetic retinopathy into one group, diabetics with no 
retinopathy into another and lastly having the normal as the third group. 
 
 50 participants in each group would be adequate to get accurate inferences while doing 
univariate analysis. Also, this would ensure that atleast 12 patients with mild, moderate, 
severe non proliferative and proliferative retinopathy were in the Diabetics-with-retinopathy 
arm. We thought that these numbers (three times the required sample size in each arm) would 
be sufficient to analyse any new subgroups which we may observe during the course of the 
study. 
 
The sample size was calculated based on hypothesis testing for 2 means, using the formula: 
 
 
n=  2sp
2
[Z1-alpha/2 + Z1- beta]
2
  / ud
2
 
 
 
Where sp
2
 =( s1
2
 + s2
2 
)
 
/ 2 
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S1
2
 : standard deviation in the first group 
S2
2
 : standard deviation in the second group 
Ud
2
 : mean difference between the samples 
Alpha: significance level 
1-beta: power 
 
 
In the analysis, all data was analysed using SPSS software version 20.0, along with Microsoft 
Excel 2010. To assess the clinical significance of each statistical question asked, t-test for 
equality of means was used.  
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Results 
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The total number of participants included in the study was 172. 3 Patients, who were 
screened to be selected in the No DM arm, who were found to have raised HbA1c (>6.5 
mg/dl) were taken out of the study and referred to Department of Medicine, CMC Vellore.  
 
4 patients enrolled were not able to sit by the slit lamp for the period of time required and 
therefore the quality index was not 1 or 2 in these participants. Therefore, they were taken out 
of the study.  
 
One of the patients had a neck ailment and mechanically found it difficult to place her chin 
on the chin rest on the slit lamp. Though not mentioned in the criteria, she was not selected in 
the study for obvious reasons.  
 
3 patients refused to undergo blood tests to confirm absence of Diabetes. All three were 
women. Two of them felt that they were too anaemic for blood tests and the third did not 
want to be poked repeatedly after the trained nursing staff failed to get a vein in two attempts. 
Therefore, these 3 women were not included in the study.  
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Mean OPA among patients with no Diabetes or Hypertension: 
The total number of patients with no Diabetes group was 53. The mean ocular pulse 
amplitudes in this group was 2.83± 0.94 .  This represents the ocular pulse amplitudes among 
the “normal” population, with no systemic illnesses.  
 
Gender-wise number of patients: 
Out of these 172, the number of males were 83 and the number of females were 89. All the 
patients were from South India. One patient was originally from West Bengal but was living 
in Vellore during examination. 
 
Figure No.1   Gender distribution 
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Table No.1:  Comparison between OPA of males and females 
 
sex N 
Mean OPA ± 
SD 
Male 83 2.65 ± 0.96 
Female 89 2.60 ± 0.95 
OPA in mm Hg.  
 
The mean OPA of men was 2.647 and for women was 2.60. It failed to show a significant 
difference in OPA with  p=0.769 .  
Subgroup analysis was done comparing significance of difference between mean OPA among 
men and women. None of the 3 sub-group analysis had any significant difference. (Table 
No.2) 
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Table No.2: Comparison of males and females in various subgroups 
   
 
 
 
 
 
 
 
 
 
 
Age wise distribution: 
The age of patients enrolled in the study ranged from 40 to 79 years.  The decade wise 
distribution of participants is shown in Figure 2. Majority of the patients were in the 5
th
 
decade with almost similar number s in the 4
th
 and 6
th
 decade. There were only 5% of 
participants in the 71- 80 year age group. The graph below shows the distribution of the 
number (in absolute numbers) of participants in each group. 
 
No DM number Mean OPA± 
SD 
T-test 
significance 
(comparing 
males and 
females) 
males 29 2.63±0.90  
 
0.12 
females 24 3.05±0.94  
DM NO DR 
(n=66) 
   
Males 22 2.68±0.96 
 
 
0.15 
females 44 2.46±0.73  
DM +DR (n=53)     
Males 32 2.31±0.88  
Females 21 2.87±1.34 0.069 
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FigureNo.1b. age wise distribution of patients 
 
 
 
Table No. 3: Mean OPAs among patients grouped by decade 
Age yrs number Mean PA  ± SD 
40-50 48 2.63±1.07 
51-60 71 2.60±0.89 
62-70 45 2.62±0.90 
71-80 8 2.84±1.19 
mean 172 2.63±0.95 
OPA in mm Hg. 
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The mean OPA was almost the same in all the groups being considered. The mean OPA 
among the 172 population considered was 2.625. We took the subgroup 71-80 and cross 
tabulated with the mean OPA to see if the difference was significant. There was no 
significant difference seen ; p= 0.54.   
 
Table No. 4:  Significance of difference in OPA between groups based on 
age 
 
Sum of 
Squares Df 
Mean 
Square F Sig. 
Between 
Groups 
.405 3 .135 .146 .932 
Within Groups 155.413 168 .925   
Total 155.817 171    
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ANOVA was done to see if there was any significant difference between any of the sub 
groups. The table above shows the same. The test failed to show any significant difference 
between the four groups. P=0.932 
 
 
SUB GROUP ANALYSIS: 
 
Analysis between the 3 major sub groups: 
 
As described in the methodology, there were 3 subgroups that we had selected. Group 1 was 
No DM, group2 DM with no DR, and Group 3, DM with DR.  Given below is the 
distribution of these 3 subgroups. 
 
The No DM group had 53, the group with DM and No DR had 66  and the DM with DR 
group had 53. The study criteria was to select a minimum of 50 participants per sub group, 
which was achieved. These groups formed 31%, 31% and 38% respectively. 
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Figure No. 2   Percentage of patients without DM, with DM and no DR, 
with DM and DR 
n=53,( 31%)
n=66, (38%)
n=53, (31%)
Distribution of subgroups
noDM
DM with no DR
DM with DR
 
In the DM with DR subgroup, Diabetics were further divided into 3 groups based on the 
severity of the retinopathy:  mild diabetic retinopathy, moderate retinopathy and severe non 
proliferative retinopathy and proliferative retinopathy. 
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Table No.5:   Analysis between the 3 major subgroups 
 
 
number Mean OPA ± 
SD 
t-test 
(compared to 
controls) 
No DM  53 2.83 ± 0.94  
DM no DR 66 2.54 ± 0.81 0.068 
DM and DR 53 2.53 ± 1.11 0.13 
     OPA in mm Hg. 
 
Comparison of the groups DMnoDR with DM+DR: 
There was no significant difference between the two groups. P= 0.972 .  
 
Distribution of patients in each stage of Diabetic retinopathy: 
Out of the 53 in the Diabetics with retinopathy arm, 14 were with mild non proliferative 
diabetic retinopathy, 18 with moderate retinopathy and 21 with severe non proliferative and 
proliferative diabetic retinopathy. 
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Figure no.3: Distribution of patients in each stage of Diabetic retinopathy 
 
 
The average Ocular pulse amplitude among the 3 groups are as shown: 
Table No.6:   Mean OPA of patients in various stages of retinopathy  
Group number Mean OPA± SD t-test (compared 
to controls) 
No diabetes 
(controls) 
53 2.83 ± 0.94  
Diabetes with no 
retinopathy 
66 2.54± 0.81  
Mild NPDR 14 2.70± 1.51 0.69 
Moderate NPDR 18 2.66± 0.93  0.50 
Severe NPDR , 
PDR 
21 2.31± 0.95 0.034 
OPA in mm Hg. 
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There was a significant decrease in mean OPA in those with severe pre-proliferative and 
proliferative diabetic retinopathy.  
 
 
Comparison of LASER therapy on values of OPA among severe NPDR- PDR groups: 
Out of the 21 patients with severe non proliferative + proliferative diabetic retinopathy 
subgroup, 11 had had no LASER therapy and the rest of the patients had LASER .  
 
 
Figure NO.3b   Subgroup severe NPDR, PDR – history of LASER therapy 
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Table No.7: Comparison of patients with and without LASER in patietns 
with severe NPDR/ PDR 
 
 
 
*OPA in mm Hg 
 
 
 
Hypertension among Non-Diabetics and Diabetics: 
 
Though Hypertension was not an exclusion criteria for selection of participants with no 
Diabetes, it was found that patients with Hypertension without Diabetes were very few. Also, 
there were 2 patients in whom Diabetes was found on doing HbA1c , both of whom claimed 
that they had Hypertension but no Diabetes.  
 
Severe 
NPDR/PDR n Mean OPA* ± SD 
No LASER 11 2.33 ± 0.86 
LASER 10 2.28 ± 1.09 
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The pie chart illustrates the point that the total percentage of patients with Hypertension but 
no diabetes was rare. 
 
Out of the 53 non diabetics, only 5 were Hypertensives with documented absence of 
Diabetes. This formed only 8% of the total Hypertensives in this subgroup. 
 
. 
 
 
 
 
 
 
Figure no.4   Percentage of non diabetics with Hypertension 
 
 
 
n=5, 
(8%)
n=48, (92%)
history of Hypertension among non-
DIabetics
hypertensive
no hypertensive
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On the other hand, out of the patients with Diabetes, 42% had Hypertension, all of them were 
on medications. The rest of them underwent blood pressure checks and were found not  to be 
Hypertensives. The method of blood pressure measurement has been described under 
methodology. 
 
 
 
 
 
Figure no. 5  Percentage of Hypertensives among Diabetics 
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Among the diabetic patients who had retinopathy, lower OPA was found in those patients 
who had no hypertension as compared to those who were hypertensive. (p= 0.05). It was 
significantly lower OPA as compared to controls as well. (p=0.02 )  
 
The OPA in the various categories of patients in the presence and absence of hypertension is 
depicted in table 8 
 
Table No.8: Comparison of Hypertension among various subgroups: 
 
 N(number 
in each 
category) 
Mean OPA`± 
SD 
t-test 
analysis 
No DM , 
No HTN 
48 2.80 ± 0.91  
No DM, 
HTN + 
5 3.14 ± 1.18 0.44 
DM , No 
HTN 
69 2.40 ± 0.93  
DM , HTN 
+ 
50 2.73 ± 0.96 0.06 
DM , no 
DR, HTN+ 
30 2.61 ± 0.67  
DM, no 
DR, no 
HTN 
36 2.48 ± 0.91 0.53 
DM, DR+,  
no HTN 
33 2.30 ± 0.95  
DM, DR+, 
HTN+ 
20 2.90 ± 1.28 0.056 
OPA in mm Hg.  
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Type of anti Hypertensives taken by those with Hypertension: 
Anti-Hypertensive medications taken by these patients were also documented. All the 
patients were only on one antihypertensive. The results are as follows: 
 
 
Table No. 9:  Antihypertensive medications 
 
 
Antihypertensive  
Medications 
Number Percentage among 
Hypertensives (%) 
Beta Blockers 9 18 
Calcium channel 
blockers 
2 4 
ACE inhibitors 19 38 
Angiotensin 
Receptor blockers 
1 2 
thiazides 6 12 
No documented Rx 13 26 
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The above table shows a significant percentage of patients who were not on treatment despite 
being on medications for Diabetes and knowing that they had Hypertension. It was beyond 
the scope of the study to determine why these participants were not on antihypertensives 
despite knowing they had Hypertension. 
 
 
 
 
 
 
Figure No.6   Patients on Antihypertensive medications in  percentages 
 
 
The numbers were not adequate to compare between Hypertensives with various 
antihypertensives. ANOVA done with the above data showed a significance of only 0.159.  
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Table No.10:  Mean OPA among Hypertensives on antihypertensives 
Antihypertensive used N Mean OPA  
±SD 
Beta blockers 9 2.31±0.46 
Calcium channel 
blockers 
4 2.16±0.99 
ACE inhibitors 19 3.10±0.75 
Angiotensin receptor 
blockers 
1 3.57 
Thiazides 6 2.60±0.88 
No documented therapy 11 2.59±0.39 
 
 
ACE inhibitors trended to show increased ocular pulse amplitudes as compared to the other 
antihypertensives used.  
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DISCUSSION 
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Various ocular perfusion abnormalities at micro and macrovascular levels as well as defects 
in autoregulation occur in diabetics. Changes in the retinal capillary endothelium and 
pericytes, causing  various manifestations of diabetic retinopathy have been well established.  
Choroidal  changes have also been documented in diabetics(26,4) 
 
Different studies on ocular blood flow and OPA have shown varying results. The varied 
results could be due to  
1) the different methods used to study the ocular blood flow. It is possible that some 
methods measure the flow in the smaller choroidal vessels and some probably measure the 
flow in the larger choroidal vessels.  
 2) The fact that the POBF could vary with the duration of diabetes,  with  diabetics of 
shorter duration having  higher POBF as compared to those with longer duration of diabetes.   
 
This could explain the varied results of POBF in the category of patients with DM but no DR 
with some studies showing no change (49)and other studies showing decreased blood flow 
(32,35). 3) Acute changes in the blood sugar levels can lead to varied ocular blood flow. 
Bursell et al found that acute hyperglycemia resulted in increased retinal blood flow in 
diabetics with no retinopathy.(57) 4)  
 
Most  studies of ocular blood flow  and OPA in diabetics  have not looked at the confounding 
effect of co-existing hypertension. Hypertension causes increased retinal perfusion pressure 
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as well as altered choroidal perfusion. Whether this will result in increased OBF will depend 
on the extent of change in the intraocular vessels, both choroidal and retinal, as well as the 
state of the general circulation. Simple extrapolation of haemodynamic principles make it 
possible to theorise that increased blood pressure could result in increased tissue blood supply 
or, paradoxically, a decreased blood supply when the vessels are grossly narrowed. Thus, the 
effect of hypertension on ocular blood flow can be highly variable and dependant on 
individual factors in the local circulation which may not be possible to measure and assess. 
 
In our study, the mean OPA in the control group (non-diabetic, non-hypertensive , n= 48) 
was  2.80 ± 0.91 mm Hg which is comparable to the OPA as measured by DCT in other 
studies- Kaufmann et al(53) found a median  value of 3.0mmHg, Hoffmann et al (55) 
3.08± 0.92 mmHg among normals. 
 
Though some  studies  have shown a gender  difference in OPA (39,40) , in our study the 
mean OPA was similar in males( n= 83; 2.65 ± 0.96 mmHg) and females (n= 89; 2.60 ± 0.95 
mmHg) [ p=0.77] . Notwithstanding this, we looked for any difference in the distribution of 
males and females in the three subgroups (No DM, DM without DR, and DM with DR)   
since it could have a confounding effect on the results.  There was no statistically significant 
difference  in any of the three subgroups(p> .05 in all three subgroups). (Table no. 2)    
 
The age of patients included in our study ranged from 40 to 79 years with fewer patients (5%)  
in the 7
th
 decade(fig. 2 ). This was because many patients in this age group had dense cataract 
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which precluded a clear view to the fundus, and hence were excluded or because some of 
them could not cooperate for examination. 
 
The OPA  was similar in the three subgroups Group1:  no DM (  2.83 ± 0.94mmHg), Group 
2: DM no DR( 2.54 ± 0.81 mmHg) , Group 3: DM + DR ( 2.53 ± 1.11 mHg). 
 
Some studies (32,35) have shown a decrease in POBF and OPA  in patients with diabetes 
without retinopathy as compared to controls whereas few other studies(29) (49) have shown 
no difference. Our study did not show any difference in the OPA between these two groups   
( p=0.07). 
 
There was no difference  in OPA between controls  vs those with retinopathy (p= 0.13).  
However, on further comparing the OPA of  the subcategories of mild NPDR, moderate 
NPDR, severe NPDR + PDR  with the control group (no DR), there was a statistically 
significant difference (p=0.034 )  in the OPA between the severe NPDR+PDR group of 
patients compared to the controls. The OPA was lower (2.31± 0.95 mmHg)   in the advanced 
stages of retinopathy compared to the controls (2.83 ± 0.94 mm Hg) indicating compromised 
perfusion in this category of patients. 
 
 A few studies  (21,32) have reported similar results whereas other studies  have   reported no 
difference(11,49). Confusingly, a few other  studies have shown increased retinal blood flow, 
POBF and OPA  (20,22,30,35) in patients with PDR not treated with laser and decrease in  
retinal blood flow, POBF and OPA in PDR patients treated with laser .(20,21,29,37) 
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In our study in patients with severe NPDR or PDR (n= 21), 10 had received laser. We   
analyzed the OPA in the laser group (n=10) vs the no laser group (n=11) and found no 
difference in the OPA (p= 0.913 ). Both the laser group (2.28 ± 1.09 mmHg ; p= 0.13) and 
the no laser group (2.33 ± 0.86  mmHg; p= 0.12 ) had lower OPA compared to the control 
group (2.80±0.91 mmHg ). However the number in each category was small reducing the 
power of the study. 
 
Since hypertension can cause changes in ocular perfusion, we looked at the OPA in patients 
with and without hypertension.  In the group of patients (n= 53) with no diabetes, only 8% 
(n=5) were hypertensives. Due to this uneven distribution of hypertensives and non-
hypertensives, the  evaluation of the effect of hypertension on OPA in non-diabetics was not 
possible. 
 
On the other hand, among the diabetics, 42% were hypertensives.  Presence of hypertension 
did not show any statistically significant difference in OPA in diabetic patients with no 
retinopathy. However in diabetics with retinopathy, absence of hypertension was associated 
with lower OPA (2.30 ± 0.95mm Hg ) as compared to those had  hypertension (2.90 ± 
1.28mm Hg  ) which trended towards statistical significance   (p=0.056).  Esgin et al. (43) 
reported  similar findings of reduced POBF and OPA in diabetics without  hypertension as 
compared to controls.  
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 It would have been ideal to evaluate the difference in OPA in hypertensives and non-
hypertensives under each category of retinopathy. However this would have required much 
larger number of patients under each category of retinopathy. The small sample size under 
each category was a limitation of our study. Similarly, a much larger sample size would be 
required to evaluate the possible effects of various anti-hypertensives on the choroidal blood 
flow as evaluated by the OPA. 
 
 It is, however, interesting to speculate that the large numbers of hypertensives in our study 
population with the unpredictable effect of HT on OPA as discussed earlier may have 
contributed to the different results we obtained compared to the quoted literature. Ideally, we 
need to perform this study on persons without HT, but this is not logistically feasible owing 
to the high association of DM and HT. 
 
In our study we found the OPA is reduced (p=0.03) in the severe NPDR and PDR group 
indicating  significant reduction of  choroidal  perfusion  occurring  in the  advanced stages of 
retinopathy. The no DR, mild and moderate NPDR categories showed mean ocular pulse 
amplitudes less than the normals, though not statistically significant. This indicates probable 
progressive decrease in choroidal blood flow with increasing severity of retinopathy which is 
in keeping with the progressive pathology. 
 
 Studies have noted initial decrease (32,35)  in POBF in the diabetics with no retinopathy  and 
subsequent increase in POBF in PDR(30,35) .Increased blood flow has been attributed to 
increased bulk blood flow demands induced by tissue hypoxia (11,13). On the other hand, 
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Geyer etal  (35) attributed the increased POBF in patients with severe diabetic retinopathy to 
proliferative choroidopathy (4) , analogous to proliferative retinopathy occurring as  a 
response to ischemia . However the  occurrence of this proliferative choroidopathy as well as 
its temporal relationship with proliferative retinopathy has not been well studied. It is 
possible that in our study, the patients with severe NPDR and PDR had not yet developed 
proliferative choroidopathy and hence the choroidal Blood flow / OPA was low, thus 
indicating a diseased choroid where proliferation has not yet begun.  
 
Choroidal vessels has been studied by ICG (58) and by histopathology (59). ICG study of 
choroidal vessels would probably give an idea of the presence or absence of proliferative 
choroidopathy in our patients. However this was not a part of the present study. It would be 
interesting to see if these patients have progressively increasing POBF/ OPA as the severity 
of disease advances and titrate the OPA with serial ICG studies to document proliferative 
choroidopathy. But as patients with proliferative retinopathy have a definite indication for 
pan retinal photocoagulation, it is unethical to delay treatment and inevitably worsen 
prognosis for these patients.  
 
 Decreased OPA noted in our study and in other studies in patients who had received laser 
treatment , could probably be explained by the closure of these proliferative choroidal 
vessels. 
 
The POBF and OPA in hypertensives without any other systemic illnesses like diabetes has 
not been studied. Greishaber etal (41) , Pourjahan (42) noted no changes in OPA with  
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variation in systolic or diastolic blood pressures amongst normals. Our study also found that 
presence or absence of hypertension did not make a difference in the OPA in diabetic patients 
without retinopathy. The number of Hypertensives among non diabetics was too low to 
analyze, hence the effect of Hypertension in these patients cannot be commented upon.  
 
However, we did note reduced OPA in diabetics without hypertension as compared to 
diabetics with hypertension. Retinal capillary perfusion depends on systemic blood pressure 
and IOP and is given by the equation : 
 
 Ocular perfusion  pressure= MAP – IOP. 
[where MAP (mean arterial pressure) = diastolic BP + 1/3
rd
 (Systolic- Diastolic BP). ] 
 
 This would explain the reduced perfusion pressure and, in turn, the reduced OPA in diabetics 
with retinopathy without hypertension. However it is not discernible why similar reduced 
OPA is not seen in the category of diabetics with no retinopathy and no hypertension. This 
could be due to the complex interaction of local retinal   vasoregulation as well as choroidal 
autoregulation. Hypertension affects the perfusion in the choroidal, ophthalmic artery as well 
as posterior ciliary arteries where autoregulatory mechanisms operate  .   
 
Although choroidal vesels are innervated by autonomic system, the effect of Diabetic 
autoimmune dysfunction on choroidal blood flow has been examined in only a few studies 
and is unclear. It is likely that normal autoregulatory mechanisms are affected in diabetics 
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(51).  This makes it difficult to estimate the effect of hypertension on the ocular blood flow in 
diabetics with abnormal autoregulation.  
 
As reduction in blood pressures reduces the ocular perfusion pressures in patients with 
diabetic retinopathy who already have abnormal autoregulation, antihypertensive medications 
must be carefully titrated as very stringent reduction of blood pressures would in turn lead to 
further reduction of choroidal blood flow and possible worsening of retinopathy.  
 
From the above discussion, we see that there are a number of coexisting factors such as 
duration of Diabetes, extent of control of blood Sugars and blood pressures, presence of 
Hypertension, which have a complex interaction on the ocular perfusion. This along with the 
variation in methods used for measuring ocular perfusion would account for the varying 
results which have been reported in choroidal blood flow studies. 
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Conclusions  
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OPA is reduced in diabetics with severe NPDR and PDR as compared to normals and 
patients with milder grades of retinopathy 
 
 
Reduced OPA is seen  in non- hypertensive patients with diabetic  retinopathy  as compared 
to normals and hypertensives with diabetic retinopathy 
 
 
Further studies with larger sample sizes in each grade of diabetic retinopathy is needed to 
evaluate the exact effect of hypertension in these patients 
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APPENDIX 1 : INSTITUTIONAL REVIEW BOARD CERTIFICATE 
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APPENDIX 2: PROFORMA 
Ocular pulse amplitudes in Diabetics 
 
DATE OF TEST: 
NAME :                                                          OPA examination number:   
HOSPITAL NUMBER:    
AGE IN YEARS (circle):     40-50      51-60     61-70     71-80    
GENDER:  male  /  female 
PHONE NUMBER:     
ADDRESS: 
HISTORY OF  MEDICATIONS FOR HYPERTENSION:           YES   /   NO 
IF YES, MEDICATIONS:   beta blockers /   thiazides  /   calcium ch. Blockers  /  ACE 
inhibitors  / angiotensin receptor blocker   
HISTORY OF DIABETES:    YES  /   NO 
If no, fasting plasma glucose levels (mg/dl) :      AC:                         
Blood pressure levels:   1.                               2.  
EXAMINATION PARAMETERS:  
Eye examined:    RIGHT  /   LEFT 
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GRADE OF DIABETIC RETINOPATHY: (based on modified Airlee staging system) 
 NDR-      no diabetic retinopathy 
 NPDR-    mild to moderate non proliferative diabetic retinopathy 
SNPDR-      severe to very severe non proliferative diabetic retinopathy  
PDR-           proliferative retinopathy 
CSME:    YES/NO 
PRESENCE OF HYPERTENSIVE RETINOPATHY CHANGES:   YES  / NO  
 
EVIDENCE OF RETINAL PHOTOCOAGULATION ON FUNDUS PICTURE:    YES 
/ NO 
 
Fundus fluorescein angiography required:    YES / NO  
  
PRIMARY EYE 
(DEFAULT- RIGHT 
EYE) 
OCULAR PULSE AMPLITUDE 
(of quality score 1 or 2) 
1  
2  
3  
Average  
  
 
SECONDARY EYE 
(IF NO 
CONTRAIND.) 
OCULAR PULSE AMPLITUDE 
(of quality score 1 or 2) 
1  
2  
3  
Average  
 
 
       
89 
 
 
APPENDIX 3: INFORMED CONSENT 
 
 
 
INFORMED CONSENT 
Study number:    date: 
Name of participant: 
Hospital number: 
 
 
I confirm that I have been explained that I have been given the option of 
undergoing testing to determine ocular pulse amplitudes by dynamic contour 
tonometry. I have understood the risks and complications of this study and have 
had the opportunity to ask the investigators any questions I may have had. I 
understand that my participation in the study is voluntary and that I can leave 
the study at any given time, without having my medical care or legal rights 
being affected. I agree that the investigators and their team have the access to all 
the data that I may provide them.  I accept to share the data obtained during 
analysis in the faith that it will be used only for scientific purposes. I accept that  
my identity will not be revealed if the data be published or sent to a third party. 
I agree not to restrict the scientific use of any of the data or results that may 
arise from this study. 
 
Understanding all the above, I give my consent for taking part in the above 
mentioned study. 
 
 
 
Patient’s/ Legally acceptable representative  signature( or thumb impression) 
with date  
 
 
Signature of a witness with date 
 
 
Signature of the investigator with date 
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INFORMED CONSENT 
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Photo1: Ocular Pulse amplitudes measurement 
Photo2: The DCT instrument after mounting on a Haag Streit slit lamp 
Photo 3: The PASCAL DCT instrument with case 
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 TITLE OF THE ABSTRACT          :  Ocular pulse amplitudes in diabetics in south India 
DEPARTMENT                           :   Ophthalmology        
NAME OF THE CANDIDATE        : Ashish George Kuruvilla  
DEGREE AND SUBJECT             : MS Ophthalmology 
NAME OF THE GUIDE               :  Andrew Braganza 
OBJECTIVES: Describe the objectives of your study (maximum 30 words) 
1. To document any difference in Ocular Pulse Amplitudes with increasing severity of Diabetic 
retinopathy 
 
2. To document any difference in Ocular Pulse Amplitudes between Diabetics with and without 
systemic Hypertension 
METHODS:    Explain the clinical and statistical methods used (maximum 100 words) 
 This study was a prospective non randomised observational study to look at the ocular pulse 
amplitudes using dynamic contour tonometry in various stages of diabetic retinopathy and also in 
patients with Hypertension.  
Participants were divided into groups based on the presence or absence of Diabetes. There were 3 
groups, 50 in each group, namely: 1. No diabetes, 2. Diabetes with no diabetic retinopathy and 3. 
Diabetes with retinopathy. Participants with retinopathy were further divided into 3 sub groups: mild 
diabetic retinopathy, moderate diabetic retinopathy and severe non proliferative diabetic retinopathy 
and proliferative diabetic retinopathy being clumped into the last group 
Statistical analysis was done mostly with hypothesis testing for 2 means, from which the sample size 
was calculated. ANOVA was also used.  
 RESULTS:  Summarise the findings and conclusions of your study (maximum 90 words) 
Conclusions: 
1. OPA is reduced in diabetics with severe NPDR and PDR as compared to normals and patients 
with milder grades of retinopathy 
 
 
2. Reduced OPA is seen  in non- hypertensive patients with diabetic  retinopathy  as compared 
to normals and hypertensives with diabetic retinopathy 
 
 
3. Further studies with larger sample sizes in each grade of diabetic retinopathy is needed to 
evaluate the exact effect of hypertension in these patients 
 
 
1 
 
  
